Genscript Biotech Corp operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genscript Biotech Corp with three other
miscellaneous service companies in Asia:
Shin Nippon Biomedical Laboratories Ltd
sales of 17.24 billion Japanese Yen [US$155.89 million]
of which 75%
was Pre-Clinical Business),
Syngene International Ltd
(12.01 billion Indian Rupees [US$168.25 million]
Sosei Group Corporation
based in Japan
(18.90 billion Japanese Yen [US$170.87 million]
of which 99%
was Overseas Pharmaceutical Business).
During the year ended December of 2017, sales at
Genscript Biotech Corp were HK$1.19 billion (US$151.61 million).
increase of 33.6%
versus 2016, when the company's sales were HK$890.52 million.
This was the fifth consecutive year of sales increases at Genscript Biotech Corp
(and since 2012, sales have increased a total of 190%).
Sales of Industrial Synthetic Biology Products saw an increase
that was more than double the company's growth rate: sales were up
69.0% in 2017, from
HK$54.36 million to HK$91.89 million.